105 related articles for article (PubMed ID: 34731787)
41. Vitreous hemorrhage: A rare ophthalmic adverse effect due to imatinib treatment.
Yılmaz F; Albayrak M; Tığlıoğlu P; Tığlıoğlu M; Sağlam B; Reis Aras M; Maral S; Afacan Öztürk HB
J Oncol Pharm Pract; 2022 Apr; 28(3):725-728. PubMed ID: 34775854
[TBL] [Abstract][Full Text] [Related]
42. Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group.
Kanagal-Shamanna R; Orazi A; Hasserjian RP; Arber DA; Reichard K; Hsi ED; Bagg A; Rogers HJ; Geyer J; Darbaniyan F; Do KA; Devins KM; Pozdnyakova O; George TI; Cin PD; Greipp PT; Routbort MJ; Patel K; Garcia-Manero G; Verstovsek S; Medeiros LJ; Wang SA; Bueso-Ramos C
Mod Pathol; 2022 Apr; 35(4):470-479. PubMed ID: 34775472
[TBL] [Abstract][Full Text] [Related]
43. Retrospective Analysis of Autologous Stem Cell Transplantation for AL Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation.
Fuchida SI; Kawamura K; Sunami K; Tsukada N; Fujii S; Ohkawara H; Usuki K; Wake A; Endo S; Ishiyama K; Ueda Y; Nakamura Y; Miyamoto T; Fukuda T; Ichinohe T; Atsuta Y; Takamatsu H
Transplant Cell Ther; 2022 Feb; 28(2):76-82. PubMed ID: 34774818
[TBL] [Abstract][Full Text] [Related]
44. Imatinib can act as an Allosteric Activator of Abl Kinase.
Xie T; Saleh T; Rossi P; Miller D; Kalodimos CG
J Mol Biol; 2022 Jan; 434(2):167349. PubMed ID: 34774565
[TBL] [Abstract][Full Text] [Related]
45. A review of FLT3 inhibitors in acute myeloid leukemia.
Zhao JC; Agarwal S; Ahmad H; Amin K; Bewersdorf JP; Zeidan AM
Blood Rev; 2022 Mar; 52():100905. PubMed ID: 34774343
[TBL] [Abstract][Full Text] [Related]
46. Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial.
Gay F; Musto P; Rota-Scalabrini D; Bertamini L; Belotti A; Galli M; Offidani M; Zamagni E; Ledda A; Grasso M; Ballanti S; Spadano A; Cea M; Patriarca F; D'Agostino M; Capra A; Giuliani N; de Fabritiis P; Aquino S; Palmas A; Gamberi B; Zambello R; Petrucci MT; Corradini P; Cavo M; Boccadoro M
Lancet Oncol; 2021 Dec; 22(12):1705-1720. PubMed ID: 34774221
[TBL] [Abstract][Full Text] [Related]
47. Antidiabetic Effects of the Senolytic Agent Dasatinib.
Salaami O; Kuo CL; Drake MT; Kuchel GA; Kirkland JL; Pignolo RJ
Mayo Clin Proc; 2021 Dec; 96(12):3021-3029. PubMed ID: 34772496
[TBL] [Abstract][Full Text] [Related]
48. TP53 in Myelodysplastic Syndromes.
Jiang Y; Gao SJ; Soubise B; Douet-Guilbert N; Liu ZL; Troadec MB
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771553
[TBL] [Abstract][Full Text] [Related]
49. Cotargeting of Bcl-2 and Mcl-1 shows promising antileukemic activity against AML cells including those with acquired cytarabine resistance.
Liu F; Zhao Q; Su Y; Lv J; Gai Y; Liu S; Lin H; Wang Y; Wang G
Exp Hematol; 2022 Jan; 105():39-49. PubMed ID: 34767916
[TBL] [Abstract][Full Text] [Related]
50. Kinetics of response to first- and second-line therapies in multiple myeloma: Assessment by both M-spikes and light chains.
Lebel E; Li X; Paul H; Masih-Khan E; Bhella S; Chen C; Prica A; Reece D; Tiedemann R; Trudel S; Kukreti V
Eur J Haematol; 2022 Mar; 108(3):204-211. PubMed ID: 34767270
[TBL] [Abstract][Full Text] [Related]
51. Antagonistic, Anti-oxidant, Anti-inflammatory and Anti-diabetic Probiotic Potential of
Khan AN; Yasmin H; Ghazanfar S; Hassan MN; Keyani R; Khan I; Gohar M; Shahzad A; Hashim MJ; Ahmad A
Saudi J Biol Sci; 2021 Nov; 28(11):6069-6076. PubMed ID: 34764740
[TBL] [Abstract][Full Text] [Related]
52. Gemtuzumab-ozogamicin and blinatumomab as treatment for refractory mixed-phenotype blast crisis in chronic myeloid leukaemia.
Ovilla-Martinez R; Weber Sánchez LA; Cota-Rangel X; Baez-Islas PE
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34764108
[TBL] [Abstract][Full Text] [Related]
53. Allergic fungal rhinosinusitis caused by Neoscytalidium dimidiatum: A case report: Allergic fungal rhinosinusitis due to Neoscytalidium dimidiatum.
Raiesi O; Hashemi SJ; Yarahmadi M; Getso MI; Raissi V; Amiri S; Borjian Boroujeni Z
J Mycol Med; 2022 Mar; 32(1):101212. PubMed ID: 34758426
[TBL] [Abstract][Full Text] [Related]
54. Rare and Unusual Follow-up Sequelae of Coronavirus Disease 2019: Splenic Mucormycosis in a Renal Transplant Recipient.
Meshram HS; Kumar D; Kute VB
Transplant Proc; 2022; 54(6):1554-1556. PubMed ID: 34756650
[TBL] [Abstract][Full Text] [Related]
55. Minocycline-induced anaphylaxis mediated by antigen-specific immunoglobulin E.
Nakamura R; Tanaka A; Kinoshita H; Ishii K; Hide M
J Dermatol; 2022 Feb; 49(2):e61-e62. PubMed ID: 34755384
[No Abstract] [Full Text] [Related]
56. Different Effect of Lanthanum Carbonate and Sevelamer Hydrochloride on Calcium Balance in Patients with Moderate to Advanced Chronic Kidney Disease.
Makowka A; Nowicki M
Ther Clin Risk Manag; 2021; 17():1145-1151. PubMed ID: 34754193
[TBL] [Abstract][Full Text] [Related]
57. KLF4, DAPK1 and SPG20 promoter methylation is not affected by DNMT1 silencing and hypomethylating drugs in lymphoma cells.
Frazzi R; Cusenza VY; Pistoni M; Canovi L; Cascione L; Bertoni F; Merli F
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34751409
[TBL] [Abstract][Full Text] [Related]
58. Mice Uterine Stem Cells are Affected by Neonatal Endocrine Disruption & Initiate Uteropathies in Adult Life Independent of Circulatory Ovarian Hormones.
Singh P; Metkari SM; Bhartiya D
Stem Cell Rev Rep; 2022 Jun; 18(5):1686-1701. PubMed ID: 34750780
[TBL] [Abstract][Full Text] [Related]
59. Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial.
Forde PM; Anagnostou V; Sun Z; Dahlberg SE; Kindler HL; Niknafs N; Purcell T; Santana-Davila R; Dudek AZ; Borghaei H; Lanis M; Belcaid Z; Smith KN; Balan A; White JR; Cherry C; Ashok Sivakumar IK; Shao XM; Chan HY; Singh D; Thapa S; Illei PB; Pardoll DM; Karchin R; Velculescu VE; Brahmer JR; Ramalingam SS
Nat Med; 2021 Nov; 27(11):1910-1920. PubMed ID: 34750557
[TBL] [Abstract][Full Text] [Related]
60. Cooperative miRNA-dependent PTEN regulation drives resistance to BTK inhibition in B-cell lymphoid malignancies.
Kapoor I; Bodo J; Hill BT; Almasan A
Cell Death Dis; 2021 Nov; 12(11):1061. PubMed ID: 34750354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
